The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Browse by »
Pneumonitis (ILD), acute, severe (See also under ARDS)
No description available.
Last update :
No medias available.
Tyrosine kinase inhibitors (EGFR)
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine.
Anti-cancer drugs 2003 Sep;14;665-8 2003 Sep
Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer.
Clinical lung cancer 2013 Jan;14;55-61 2013 Jan
Imaging of gefitinib-related interstitial lung disease: multi-institutional analysis by the West Japan Thoracic Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2006 May;52;135-40 2006 May
Interstitial lung disease associated with gefitinib.
Respiratory medicine 2006 Apr;100;698-704 2006 Apr
Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients.
PloS one 2011;6;e22062 2011
Severe acute interstitial pneumonia and gefitinib.
Lancet (London, England) 2003 Jan 11;361;137-9 2003 Jan 11
Successful treatment of gefitinib-induced acute interstitial pneumonitis with corticosteroid and non-invasive BIPAP-ventilation.
Journal of thoracic disease 2012 Jun 01;4;316-9 2012 Jun 01